These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1625717)

  • 1. The risk of transfusion-transmitted infection.
    Dodd RY
    N Engl J Med; 1992 Aug; 327(6):419-21. PubMed ID: 1625717
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current status of transfusion-transmitted infection].
    Shimizu M
    Rinsho Ketsueki; 1993 Apr; 34(4):411-7. PubMed ID: 8510326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.
    Kleinman S; Busch MP; Korelitz JJ; Schreiber GB
    Transfus Med Rev; 1997 Jul; 11(3):155-72. PubMed ID: 9243769
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 5. [Viral safety of blood and blood products].
    Gürtler L
    Fortschr Med; 1993 Nov; 111(33):526-7. PubMed ID: 8307536
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
    Dwyre DM; Fernando LP; Holland PV
    Vox Sang; 2011 Jan; 100(1):92-8. PubMed ID: 21175659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of the Ministry of Health in the prevention of diseases caused by blood transfusion].
    Wolpert Barraza E; Córdova MS; Robles Díaz G; Reyes López PA
    Gac Med Mex; 1994; 130(6):412-24. PubMed ID: 7557054
    [No Abstract]   [Full Text] [Related]  

  • 8. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of nucleic acid testing for blood donor screening of human immunodeficiency virus and hepatitis C virus in the Saudi population.
    Akhter J; Roberts GT; Perry A; Gaucher JS; Howman PA
    Saudi Med J; 2001 Dec; 22(12):1073-5. PubMed ID: 11802179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual risk of transfusion transmitted viral infections among seronegative donors: application of the incidence/window period model.
    Kleinman S
    Dev Biol (Basel); 2000; 102():61-5. PubMed ID: 10794091
    [No Abstract]   [Full Text] [Related]  

  • 11. No need for bad blood over bad blood.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2015 May; 15(5):487. PubMed ID: 25932570
    [No Abstract]   [Full Text] [Related]  

  • 12. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in monitoring blood safety.
    Epstein JS; Holmberg JA
    Transfusion; 2010 Jul; 50(7):1408-12. PubMed ID: 20636529
    [No Abstract]   [Full Text] [Related]  

  • 14. The legacy of unhygienic plasma collection in China.
    Mastro TD; Yip R
    AIDS; 2006 Jun; 20(10):1451-2. PubMed ID: 16791021
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
    Koch C; Araújo F
    Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV infection in blood donors.
    James V
    Br J Hosp Med; 1994 Nov 16-Dec 13; 52(10):541. PubMed ID: 7858808
    [No Abstract]   [Full Text] [Related]  

  • 17. HCV infection in blood donors.
    Finch RG
    Br J Hosp Med; 1994 Nov 16-Dec 13; 52(10):541. PubMed ID: 7858807
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of introduction of PCR in blood banks].
    Gürtler L
    Infusionsther Transfusionsmed; 1996 Feb; 23(1):4-6. PubMed ID: 8653016
    [No Abstract]   [Full Text] [Related]  

  • 19. Contaminated blood.
    Machin SJ
    Med Leg J; 2004; 72(Pt 3):77-87. PubMed ID: 15524115
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review.
    Cable R; Lelie N; Bird A
    Vox Sang; 2013 Feb; 104(2):93-9. PubMed ID: 22924987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.